An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing Mutants
In cellular models we have demonstrated that a unique U1snRNA targeting an intronic region downstream of a defective exon (Exon-specific U1snRNA, ExSpeU1) can rescue multiple exon-skipping mutations, a relevant cause of genetic disease. Here, we explored in mice the ExSpeU1 U1fix9 toward two model H...
Saved in:
Main Authors: | Dario Balestra (Author), Daniela Scalet (Author), Franco Pagani (Author), Malgorzata Ewa Rogalska (Author), Rosella Mari (Author), Francesco Bernardi (Author), Mirko Pinotti (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
by: Elena Barbon, et al.
Published: (2016) -
Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
by: Saskia Breuel, et al.
Published: (2019) -
Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
by: Christoph Jüschke, et al.
Published: (2021) -
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
by: Agathe Eckenfelder, et al.
Published: (2012) -
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies
by: Claudia Sacchetto, et al.
Published: (2021)